[HTML][HTML] Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults

B Killingley, AJ Mann, M Kalinova, A Boyers… - Nature Medicine, 2022 - nature.com
Since its emergence in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) has caused hundreds of millions of cases and continues to circulate globally. To establish …

[PDF][PDF] Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge

B Killingley, A Mann, M Kalinova, A Boyers… - pflegefueraufklaerung.de
To establish a novel SARS-CoV-2 human challenge model, 36 volunteers aged 18-29 years
without evidence of previous infection or vaccination were inoculated with 10 TCID50 of a …

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults

B Killingley, AJ Mann, M Kalinova, A Boyers… - spiral.imperial.ac.uk
Since its emergence in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) has caused hundreds of millions of cases and continues to circulate globally. To establish …

[HTML][HTML] Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge

B Killingley, A Mann, M Kalinova, A Boyers… - 2022 - europepmc.org
To establish a novel SARS-CoV-2 human challenge model, 36 volunteers aged 18-29 years
without evidence of previous infection or vaccination were inoculated with 10 TCID 50 of a …

[HTML][HTML] Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults

B Killingley, AJ Mann, M Kalinova… - Nature …, 2022 - nottingham-repository.worktribe.com
Since its emergence in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) has caused hundreds of millions of cases and continues to circulate globally. To establish …

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge

B Killingley, A Mann, M Kalinova… - …, 2022 - livrepository.liverpool.ac.uk
To establish a novel SARS-CoV-2 human challenge model, 36 volunteers aged 18-29 years
without evidence of previous infection or vaccination were inoculated with 10 TCID 50 of a …

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults.

B Killingley, AJ Mann, M Kalinova, A Boyers… - Nat …, 2022 - pesquisa.bvsalud.org
Since its emergence in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) has caused hundreds of millions of cases and continues to circulate globally. To establish …

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults

B Killingley, AJ Mann, M Kalinova, A Boyers… - Nature Medicine, 2022 - ora.ox.ac.uk
Since its emergence in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) has caused hundreds of millions of cases and continues to circulate globally. To establish …

[HTML][HTML] Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge

B Killingley, A Mann, M Kalinova, A Boyers… - 2022 - researchsquare.com
To establish a novel SARS-CoV-2 human challenge model, 36 volunteers aged 18-29 years
without evidence of previous infection or vaccination were inoculated with 10 TCID 50 of a …

[HTML][HTML] Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults

B Killingley, AJ Mann, M Kalinova, A Boyers… - Nature Medicine, 2022 - nature.com
Since its emergence in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) has caused hundreds of millions of cases and continues to circulate globally. To establish …